This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
December 02, 2019
Oncopeptides appoints Joseph Horvat as President North America
December 02, 2019
Orexo appoints Dennis Urbaniak as Executive Vice President Digital Health
November 27, 2019
Orexo acquires exclusive US rights to commercialize vorvida®, a digital therapy for alcohol use disorder with scientifically proven efficacy
November 19, 2019
Interim Report Q3 2019
November 19, 2019
Nordic Nanovector ASA – Results for the Third Quarter 2019
November 18, 2019
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director
November 13, 2019
Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
November 13, 2019
Vicore Pharma has completed a directed share issue of approximately SEK 125 million
November 12, 2019
BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW
November 12, 2019
Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences